Clinical research is a vital part of the work of the NHS, helping improve treatments for patients now and in the future. Clinical trials play an important role in discovering new treatments, and making sure we use existing treatments in the best way possible. Ultimately, high-quality clinical research helps the NHS improve future healthcare. Our research at WMAS helps us to provide the best care for our patients.
Performance in Initiating and Delivering Clinical Research
The Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.
NHS providers holding National Institute of Health Research (NIHR) contracts are required to provide, on a quarterly basis, information on recruitment to clinical trials, including commercial trials. This information has been supplied to the NIHR Central Commissioning Facility as well as being published here.
The two performance benchmarks are:
- Performance in initiating clinical research:
There should not be any delay in recruiting the first participant into a trial. Reasons for any delay to be reported.
- Performance in delivering clinical research:
For all commercial clinical trials hosted by the Trust the agreed number of patients should be recruited within the agreed timescale.
The performance and delivery information pertaining to West Midlands Ambulance Service for Q2 18-19 can be found below:
- Performance in Initiating Clinical Research – During Q3 18-19 there were no trials relevant for the Performance in initiating clinical research benchmark.
- Performance in Delivering Clinical Research – During Q3 18-19 there were no commercial clinical trials hosted by the Trust.
For further information about Research at WMAS please email email@example.com